PATH-27. CLINICAL, RADIOLOGIC AND PROGNOSTIC PROFILE OF IDH WILD TYPE DIFFUSE ASTROCYTOMA WITH MOLECULAR FEATURES OF GLIOBLASTOMA

BACKGROUND: cIMPACT-NOW-3 recommends that IDH-wildtype diffuse astrocytic glioma Grade II or III with EGFR amplification, or combined whole chromosome 7 gain and whole chromosome 10 loss, or TERT promoter mutation should receive an integrated classification: Diffuse astrocytic glioma, IDH-wildtype w...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Akintola, Oluwatosin, Samore, Wesley, Alvarez, Maria Martinez-Lage, Gerstner, Elizabeth
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Molecular Pathology & Classification
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651544/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.708
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky